Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Fluorescence in situ hybridization.

Chen AY, Chen A.

J Invest Dermatol. 2013 May;133(5):e8. doi: 10.1038/jid.2013.120. No abstract available.

2.

[Fluorescence in-situ hybridization as a diagnostic tool for cutaneous melanoma].

Su J, Liu J, Zheng J, You J, Ma X, Zhang Y, Zhang J, Liao S.

Zhonghua Bing Li Xue Za Zhi. 2015 Jan;44(1):37-41. Chinese.

PMID:
25765029
3.

Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes.

Gerami P, Mafee M, Lurtsbarapa T, Guitart J, Haghighat Z, Newman M.

Arch Dermatol. 2010 Mar;146(3):273-8. doi: 10.1001/archdermatol.2009.386.

PMID:
20231497
4.

Two-dimensional visualization of multicolor FISH-generated data as a helpful tool for the analysis and understanding of cytogenetic and chromosomal alterations in melanocytic lesions.

Kerl K, Schärer L, Hesse R, Hesse B, Palmedo G, Requena L, Wiesner T, Kutzner H.

Am J Dermatopathol. 2013 Apr;35(2):151-8. doi: 10.1097/DAD.0b013e318265fd08.

PMID:
23542716
5.

The Molecular Revolution in Cutaneous Biology: Era of Cytogenetics and Copy Number Analysis.

Bauer J.

J Invest Dermatol. 2017 May;137(5):e57-e59. doi: 10.1016/j.jid.2016.11.043. Review.

PMID:
28411847
6.

Update on fluorescence in situ hybridization in melanoma: state of the art.

Gerami P, Zembowicz A.

Arch Pathol Lab Med. 2011 Jul;135(7):830-7. doi: 10.1043/2011-0048-RAIR.1. Review. Erratum in: Arch Pathol Lab Med. 2011 Oct;135(10):1237.

PMID:
21732770
7.

Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization.

Pouryazdanparast P, Newman M, Mafee M, Haghighat Z, Guitart J, Gerami P.

Am J Surg Pathol. 2009 Sep;33(9):1396-400. doi: 10.1097/PAS.0b013e3181a92cbc.

PMID:
19606012
8.

Fluorescence in situ detection of human cutaneous melanoma: study of diagnostic parameters of the method.

Chwirot BW, Chwirot S, Sypniewska N, Michniewicz Z, Redzinski J, Kurzawski G, Ruka W.

J Invest Dermatol. 2001 Dec;117(6):1449-51.

9.

Targeting multiple genetic aberrations in isolated tumor cells by spectral fluorescence in situ hybridization.

Slovak ML, Zhang F, Tcheurekdjian L, Bobadilla D, Bedell V, Arber DA, Persons DL, Sosman JA, Murata-Collins JL.

Cancer Detect Prev. 2002;26(3):171-9.

PMID:
12269763
10.

Fluorescence in situ hybridization as a diagnostic modality in melanocytic neoplasma.

Gerami P, Geraminegad P.

G Ital Dermatol Venereol. 2010 Feb;145(1):29-35.

PMID:
20197743
11.

Differences in chromosomal aberrations between nodular and superficial spreading malignant melanoma detected by interphase cytogenetics.

Poetsch M, Woenckhaus C, Dittberner T, Pambor M, Lorenz G, Herrmann FH.

Lab Invest. 1998 Jul;78(7):883-8.

PMID:
9690566
12.

Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.

Gerami P, Beilfuss B, Haghighat Z, Fang Y, Jhanwar S, Busam KJ.

J Cutan Pathol. 2011 Apr;38(4):329-34. doi: 10.1111/j.1600-0560.2010.01666.x.

PMID:
21323721
13.

Differentiation of melanoma and benign nevi by fluorescence in-situ hybridization.

Hossain D, Qian J, Adupe J, Drewnowska K, Bostwick DG.

Melanoma Res. 2011 Oct;21(5):426-30. doi: 10.1097/CMR.0b013e328347ee1d.

PMID:
21900793
14.

Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe.

Gammon B, Beilfuss B, Guitart J, Gerami P.

Am J Surg Pathol. 2012 Jan;36(1):81-8. doi: 10.1097/PAS.0b013e31822d5ff8.

PMID:
21989344
15.

What's new in prognostication of melanoma in the dermatopathology laboratory?

Bangash HK, Romegialli A, Dadras SS.

Clin Dermatol. 2013 May-Jun;31(3):317-23. doi: 10.1016/j.clindermatol.2012.08.007. Review.

PMID:
23608451
16.

Molecular diagnosis in dermatopathology: what makes sense, and what doesn't.

Braun-Falco M, Schempp W, Weyers W.

Exp Dermatol. 2009 Jan;18(1):12-23. doi: 10.1111/j.1600-0625.2008.00805.x. Epub 2008 Oct 22. Review.

PMID:
19054055
17.

[High-definition optical coherence tomography: Presentation of the technique and applications in dermatology].

Marneffe A, Suppa M, Miyamoto M, Del Marmol V, Boone M.

Ann Dermatol Venereol. 2015 Jun-Jul;142(6-7):452-5. doi: 10.1016/j.annder.2015.02.026. Epub 2015 Apr 28. Review. French. No abstract available.

PMID:
25934214
18.

Utilization of fluorescence in situ hybridization in the diagnosis of 230 mesenchymal neoplasms: an institutional experience.

Tanas MR, Rubin BP, Tubbs RR, Billings SD, Downs-Kelly E, Goldblum JR.

Arch Pathol Lab Med. 2010 Dec;134(12):1797-803. doi: 10.1043/2009-0571-OAR.1.

PMID:
21128778
19.

Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma.

Requena C, Rubio L, Traves V, Sanmartín O, Nagore E, Llombart B, Serra C, Fernández-Serra A, Botella R, Guillén C.

Histopathology. 2012 Nov;61(5):899-909. doi: 10.1111/j.1365-2559.2012.04293.x. Epub 2012 Aug 8.

PMID:
22882594
20.

Molecular diagnostic strategies: a role in the practice of dermatology.

Elaba Z, Phelps A, Murphy MJ.

Int J Dermatol. 2012 Nov;51(11):1292-302. doi: 10.1111/j.1365-4632.2011.05439.x. Review.

PMID:
23067076

Supplemental Content

Support Center